Dealmaking Quarterly Statistics, Q3 2021
A look at M&A and alliance activity across the biopharma, medical device and in vitro diagnostics industries, July-September 2021
In the third quarter of 2021, medical device company M&A values reached $7.1bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $6.7bn.
